Authors:
SCOTT CB
SCARANTINO C
URTASUN R
MOVSAS B
JONES CU
SIMPSON JR
FISCHBACH AJ
CURRAN WJ
Citation: Cb. Scott et al., VALIDATION AND PREDICTIVE POWER OF RADIATION-THERAPY ONCOLOGY GROUP (RTOG) RECURSIVE PARTITIONING ANALYSIS CLASSES FOR MALIGNANT GLIOMA PATIENTS - A REPORT USING RTOG-90-06, International journal of radiation oncology, biology, physics, 40(1), 1998, pp. 51-55
Authors:
WOOD L
PALMER M
HEWITT J
URTASUN R
BRUERA E
RAPP E
THAELL JF
Citation: L. Wood et al., RESULTS OF A PHASE-III, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MEGESTROL-ACETATE MODULATION OF P-GLYCOPROTEIN-MEDIATED DRUG-RESISTANCE IN THE FIRST LINE MANAGEMENT OF SMALL-CELL LUNG-CARCINOMA, British Journal of Cancer, 77(4), 1998, pp. 627-631
Authors:
SCOTT CB
CHOUCAIR AK
URTASUN R
NELSON D
COIA L
CURRAN WJ
Citation: Cb. Scott et al., THE INFLUENCE OF COMPLIANCE ON THE INTERPRETATION OF RESULTS FROM THERADIATION-THERAPY-ONCOLOGY-GROUP STUDY-91-14, Quality of life research, 6(5), 1997, pp. 30-30
Authors:
PRADOS M
SCOTT C
PHILLIPS T
DAVIS R
SANDLER H
BUCKNER J
CURRAN W
SCHULTZ C
URTASUN R
Citation: M. Prados et al., PHASE-III RANDOMIZED STUDY OF RADIOTHERAPY PLUS PCV WITH OR WITHOUT BUDR FOR THE TREATMENT OF ANAPLASTIC ASTROCYTOMA RTOG-9404 INTERIM-REPORT, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 138-138
Authors:
CHOUCAIR AK
SCOTT C
URTASUN R
NELSON D
MOUSAS B
CURRAN W
Citation: Ak. Choucair et al., QUALITY-OF-LIFE AND NEUROPSYCHOLOGICAL EVALUATION FOR PATIENTS WITH MALIGNANT ASTROCYTOMAS - RTOG-91-14, International journal of radiation oncology, biology, physics, 38(1), 1997, pp. 9-20
Citation: D. Fulton et al., PHASE-II STUDY OF PROLONGED ORAL-THERAPY WITH ETOPOSIDE (VP16) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA, Journal of neuro-oncology, 27(2), 1996, pp. 149-155